Lv3
377 积分 2023-05-24 加入
Mechanisms of resistance to antibody–drug conjugates in cancers
16天前
已完结
Mechanisms of resistance to antibody-drug conjugates in cancer therapy: molecular basis and therapeutic strategies
16天前
已完结
Antibody-Drug Conjugates in Solid Tumor Oncology and the Frontier of Precision Immunosuppression: A Mechanistic, Translational, and Clinical Review
19天前
已完结
Characterization of zolbetuximab in pancreatic cancer models
20天前
已完结
Effect of anti-claudin 18.2 monoclonal antibody zolbetuximab alone or combined with chemotherapy or programmed cell death-1 blockade in syngeneic and xenograft gastric cancer models
20天前
已完结
Development of a Humanized VHH Based Recombinant Antibody Targeting Claudin 18.2 Positive Cancers
22天前
已完结
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy
26天前
已完结
Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in Neuroblastoma
26天前
已完结
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers
26天前
已完结
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers
1个月前
已完结
皖公网安备34019202002308
